CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1 ‐Mediated NRF2 Degradation Leading to Ferroptosis
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Xinqiao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Hospital of China Medical University, Heping District, Shenyang, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Glioblastoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Provincial Science and Technology Department, Department of Science and Technology of Liaoning Province.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis and resistance to temozolomide (TMZ). The role of downregulated circular RNAs (circRNAs) in GBM progression remains unclear.
Methods
CircRNA sequencing and public dataset analysis identified dysregulated circRNAs in GBM. Functional assays were conducted in patient‐derived glioma stem‐like cells (GSCs) with circMAN1A2 overexpression or knockdown. Ferroptosis‐related experiments, protein interaction assays, and in vivo mouse models were used to explore mechanisms and therapeutic effects.
Results
CircMAN1A2 was significantly downregulated in GBM tissues and inversely correlated with WHO grade and patient survival. Overexpression of circMAN1A2 inhibited GSC proliferation, stemness, invasion, and reversed TMZ resistance by inducing ferroptosis. Mechanistically, circMAN1A2 was regulated by PRPF40B and directly bound to TEP1, disrupting its interaction with KEAP1, thereby promoting NRF2 degradation and ferroptosis. NRF2 upregulated ANXA1, which promoted tumor‐associated macrophage (TAM) recruitment and M2 polarization. In vivo, circMAN1A2 overexpression suppressed tumor growth, enhanced TMZ sensitivity, and reduced NRF2/ANXA1 expression, effects reversed by TEP1.
Conclusions
CircMAN1A2 suppresses GBM progression and TMZ resistance by inducing ferroptosis and modulating the TEP1–KEAP1–NRF2–ANXA1 axis. It represents a potential therapeutic target in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Hospital of China Medical University, Heping District, Shenyang, China.
- Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China.
- Department of Cardiac Surgery, Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Anesthesiology, Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou, China.
- School of Clinical Medical, Southwest Medical University, Luzhou, China.
- Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
ORCID-Profile: Zhitao Jing
Förderung
- National Natural Science Foundation of China
- Liaoning Provincial Science and Technology Department
- Department of Science and Technology of Liaoning Province
Zitieren
APA
Li, X., Hu, J., Zheng, W., Fan, Z., Chi, H., Li, H., Wang, Y., & Jing, Z. (2025). CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1 ‐Mediated NRF2 Degradation Leading to Ferroptosis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70489
Vancouver
Li X, Hu J, Zheng W, Fan Z, Chi H, Li H, et al. CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1 ‐Mediated NRF2 Degradation Leading to Ferroptosis. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70489
BibTeX
@article{Li2025,
author = {Li, Xinqiao and Hu, Jinpeng and Zheng, Wei and Fan, Zongming and Chi, Hao and Li, Hao and Wang, Yongfeng and Jing, Zhitao},
title = {CircMAN1A2 Levels Determine GBM Susceptibility to TMZ in a Pathway Involving TEP1‐ and KEAP1 ‐Mediated NRF2 Degradation Leading to Ferroptosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70489}
}
EUVIMED